查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球动物肠道健康市场-2022-2029
市场调查报告书
商品编码
1129257

全球动物肠道健康市场-2022-2029

Global Animal Intestinal Health Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

预计动物肠道健康意识的提高将推动市场增长。

全球动物保健公司奥特奇为畜禽养殖户提供有机营养补充剂。该公司以肠道健康为重点，建立了“全技术抗生素减少计划”，以生产始终健康的动物并减少预防性和准抗生素的使用。该计划帮助奶农制定行动计划。该计划适用于希望采取行动改善畜群和绵羊健康的牲畜所有者。一组专家为生产者提供建议和指导。奥特奇肠道健康平台的行业顾问、兽医和营养师通过制定定制的行动计划和提供支持来帮助种植者减少农场的抗生素使用。例如，在英国的一个养猪场，奥特奇的抗生素减少计划得到了全面实施。因此，农民和动物生产者的意识不断增强，增加了对动物肠道健康补充剂的需求。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

约束

与用于肠道健康的饲料添加剂相关的价格上涨、用于开发非抗生素生长促进剂的活性成分成本上涨以及对各种饲料添加剂的严格监管 在预测期内，预计有几个因素会阻碍市场.

行业分析

动物肠道健康市场基于供应链分析、价格分析等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对市场产生了适度的影响。 COVID-19 流行期间的交通限制和其他社会排斥因素大大减少了动物供应和生产力。 COVID的最初影响引发了恐慌性购买并增加了肉类和奶製品的销售。因此，大流行将扰乱牛产品的供应炼和流程。许多公司转移到其他地区以维持产品供应并保护其供应链。因此，从上面这句话来看，市场受到了影响，预计随着经济活动的恢復，市场将迅速获得牵引力。

全球动物肠道健康市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页内容。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 预计动物肠道健康意识的提高将推动市场增长。
    • 限制因素
      • 用于肠道健康的饲料添加剂价格上涨预计将阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章通过饲养动物

  • 水产养殖
  • 家禽
  • 反刍动物
  • 猪
  • 其他

第 8 章来源

  • 微生物来源
  • 植物来源

第 9 章形态学

  • 烘干
  • 液体
  • 其他

第 10 章添加剂

  • 益生菌
  • 益生元
  • 免疫刺激剂
  • 植物性
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 13 章公司简介

  • AB Vista
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Nutrition & Biosciences
  • Kemin Industries, Inc.
  • Lesaffre
  • Adisseo
  • Cargill, Incorporated
  • Evonik Industries
  • Novozymes
  • Pure Cultures
  • Chr. Hansen Holdings

第 14 章全球动物肠道健康市场-DataM

简介目录
Product Code: DMVH5845

Market Overview

Animal Intestinal Health Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Animal intestinal health defines gut health as physiological and functional elements, such as nutrition digestion and absorption, host metabolism and energy production, a stable and functional microbiota/microbiome, defensive systems, and the interactions between these elements. Good health is a prerequisite for any animal to fulfill its genetic potential. The connections to daily increases, regularity, and feed conversion are obvious. Diet has a bearing on health, especially regarding reducing risks and curing disorders. Animal husbandry can impact one's health almost any way, and animal nutrition is no exception.

Market Dynamics

Rising awareness regarding animals' intestinal health is expected to drive market growth.

Global animal health company Alltech offers organic dietary supplements to farmers raising livestock and poultry. By putting a strong emphasis on gut health, the company has established an Alltech Antibiotic Reduction program to produce consistently healthy animals and decrease prophylactic and metaphylactic antibiotic use. The program can help the farmer create an action plan. This program is for livestock owners who are dedicated to taking action to improve the health of their herd or flock. A group of professionals advises and mentor the producer. The Alltech Gut Health Platform's industry advisors, veterinarians, and nutritionists support producers in reducing farm antibiotic use by developing a customized action plan and offering support. For instance, The full Alltech Antibiotic Reduction program was implemented on a pig farm in the United Kingdom. Therefore, increasing awareness among farmers and animal producers has increased the demand for animal intestinal health supplements. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

Increasing prices associated with feed additives utilized for intestinal health, rising expense of active ingredients used in the development of non-antibiotic growth promoters, and stringent regulations regarding different feed additives are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The animal intestinal health market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. Due to transportation limitations and other social exclusionary factors during the COVID-19 epidemic, animal supplies and productivity drastically decreased. The first impact of COVID led to panic buying, which increased sales of meat and dairy products. Therefore, the pandemic interrupts the supply chain and process for cattle products. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Probiotics segment is expected to hold the largest market share in animal intestinal health market

The probiotics segment is expected to dominate in 2021. Probiotics make up a sizable portion of the feed supplements utilized in the cattle business. When properly ingested, probiotics, which are microbial feed supplements, help the host's health. Fish and animals may develop healthier and more rapidly with the help of probiotics. It also aids in speeding up an animal's digestion. It is being utilized more frequently to improve cattle performance as a safe and effective substitute for antibiotics. Animal growth, immunological response, nutrient digestibility and absorption, gut microbiota composition, and meat quality were all improved by probiotics.

Moreover, more significant research describing particular strains, determining the ideal dosage, and comprehending the network of interactions between probiotics and the gut microbiota may aid in creating probiotic mixes for animal feed and meat products that are more successful. Farm animals treated with probiotics had lower morbidity and vitality, improved eating habits, and produced more. Additionally, their application has expanded in the food business due to probiotics' capacity to suppress a wide variety of harmful bacteria. Probiotic supplements also contributed to the increase in broiler chicken body weight. Therefore, it has increased the demand for probiotics. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global animal intestinal health market

In 2021, North America accounted for the highest revenue share. Increasing consumption of meat and dairy products, growing livestock count and the associated animal feed required for the healthy maintenance of the livestock and product launches by the region's key market players are some factors the market is expected to boost in the forecast period. For instance, According to the United States Department of Agriculture Economic Research Service, the country produced more than 2,26,258 million pounds of milk in 2021. Moreover, to feed the gastrointestinal tract in calves, optimize average daily gains, support calf immune system development, and reinforce a healthy gut microbiome without using antibiotics at any stage of production, Alltech released Bio-Mos 2 as a second-generation feed additive in April 2022. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the animal intestinal health market are AB Vista, Nutrition & Biosciences, Kemin Industries, Inc., Lesaffre, Adisseo, Cargill, Incorporated, Evonik Industries, Novozymes, Pure Cultures, Chr. Hansen Holdings.

Kemin Industries, Inc.:

Overview:

Kemin was established in 1961 and headquartered in Des Moines, Iowa. It offers molecules that have been specially created to assist both human and animal health and nutrition. The company is dedicated to the safety of food and feed. It maintains production facilities where specialized ingredients are created for the food and feed industries and the health, nutrition, and beauty sectors. Moreover, the business involves pharma, food technologies, nutrisurance, and personal care.

Product Portfolio:

COZANTE: A patented polyphenol from plants called COZANTE is used to help chicken farms reduce Eimeria species. Its active component is delivered using Kemin's unique spray freezing technology (SFT) of encapsulation. This procedure will deliver the active substance evenly along the gut length.

The global animal intestinal health market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising awareness regarding animals' intestinal health is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing prices associated with feed additives utilized for intestinal health is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Live Stock

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 7.1.2. Market Attractiveness Index, By Live Stock Segment
  • 7.2. Aquaculture*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Poultry
  • 7.4. Ruminant
  • 7.5. Swine
  • 7.6. Others

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source Segment
  • 8.2. Microbial*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Plant Based

9. By Form

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2. Market Attractiveness Index, By Form Segment
  • 9.2. Dry*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Liquid
  • 9.4. Others

10. By Additive

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 10.1.2. Market Attractiveness Index, By Additive Segment
  • 10.2. Probiotics*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Prebiotics
  • 10.4. Immunostimulants
  • 10.5. Phytogenics
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. AB Vista*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Nutrition & Biosciences
  • 13.3. Kemin Industries, Inc.
  • 13.4. Lesaffre
  • 13.5. Adisseo
  • 13.6. Cargill, Incorporated
  • 13.7. Evonik Industries
  • 13.8. Novozymes
  • 13.9. Pure Cultures
  • 13.10. Chr. Hansen Holdings

LIST NOT EXHAUSTIVE

14. Global Animal Intestinal Health Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us